Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Cyclophosphamide for Treatment of Systemic Sclerosis (Scleroderma)

NCT00501995 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT00501995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00501995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Cyclophosphamide for Treatment of Systemic Sclerosis (Scleroderma)
Lead sponsor
Johns Hopkins University
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2001
Completion date
May 31, 2010
Enrollment
6 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

scleroderma